The bacteria usually trigger infections that are resistant to certain antibiotics, making them life-threatening. The CDC reports the outbreak may be linked to a contaminated liquid docusate product, and recommends until more information is available hospitals should refrain from using such products in patients who are immunosuppressed, have chronic respiratory illness, or are critically ill or ventilated.
“Institutions with non-cystic fibrosis patients in whom there are B. cepacia infections should sequester all liquid docusate products,” the CDC statement reads.
The CDC urges providers to report all cases of B. cepacia infection to local and state health authorities, and has promised an update to its initial announcement this week.
More articles on infection control:
CDC funds 5 Prevention Epicenters to focus on infection prevention tactics
CDC official: Zika is the ‘most difficult’ emergency response ever
New antimicrobial material also prevents bacteria from growing, researchers say
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
